Aschenbrenner, Diane S.2017-09-272017-09-272015-01Aschenbrenner, D. S. (2015). Asthma medication receives new warning. AJN American Journal Of Nursing, 115(1), 22-23. doi:10.1097/01.NAJ.0000459621.92420.e0http://dx.doi.org/10.1097/01.NAJ.0000459621.92420.e0http://hdl.handle.net/11603/5651The labeling of omalizumab (Xolair), a drug used to treat allergic asthma, now carries a warning that its use may slightly increase the risk of cardiovascular complications. The drug may also pose an increased risk of inducing cancer.2 pagesen-USText